Radiochemistry and Pre-clinical First Steps

  • University College NHS Foundation Trust and University College London

Abstract

Radiochemistry is integral to tracer development, not only to enable labelling of putative tracers for early pre-clinical evaluation, but also to bridge efforts in medicinal chemistry, biological evaluation, tracer selection, method development, and tracer production for early human studies. INM has historically relied on access to experimental radiotracers through national and international collaborations, and it has been a long-term strategic goal for the Institute to establish its own radiochemistry group in order to stay at the forefront of nuclear imaging.

Keywords

Drug Efflux Pump Tracer Development Tracer Production Experimental Radiotracer Tracer Selection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Stone JM, Erlandsson K, Årstad E, Squassante L, Teneggi V, Bressan RA, Krystal JH, Ell PJ, Pilowsky LS (2008). Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Psychopharmacology 197(3), 401–408.PubMedCrossRefGoogle Scholar
  2. Stone J.M., Erlandsson K., Årstad E., Bressan R.A., Squassante L., Teneggi V., Ell P.J., Pilowsky L.S. (2006), Ketamine displaces the novel NMDA receptor SPET probe [123I]CNS-1261 in humans in vivo, Nuclear Medicine and Biology, 33(2), 239–43.PubMedCrossRefGoogle Scholar
  3. Stone J.M., Årstad E., Erlandsson K., Waterhouse R.N., Ell P.J., Pilowsky L.S. (2006), [123I]TPCNE – A novel SPET tracer for the sigma-1 receptor: First human studies and in vivo haloperidol challenge, SYNAPSE, 60(2); 109–107.PubMedCrossRefGoogle Scholar
  4. Årstad E., Gitto R., Chimirri A., Caruso R., Constanti A., Turton D., Hume S.P., Ahmad R., Pilowsky L.S., Luthra S.K (2006). Closing in on the AMPA receptor: Synthesis and evaluation of 2-acyl-1-(p-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracer, Bioorganic & Medicinal Chemistry, 14 (14), 4712–4717.CrossRefGoogle Scholar
  5. Årstad E, Wester HJ, Luthra SK, Pilowsky LS, Henriksen G (2006), Towards NR2B subtype selective PET tracers: Synthesis and Evaluation of styrene-, naphthyl and 4- trifluoromethoxyphenyl N-(2-[11-C] methoxybenzyl) amidine, Bioorganic & Medicinal Chemistry, 14(18), 6307–6313.CrossRefGoogle Scholar
  6. Schoultz BW, Hjornevik T, Willoch F, Marton J, Noda A, Murakami Y, Miyoshi S, Nishimura S, Årstad E, Drzezga A, Matsunari I, Henriksen G (2010). Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques. Eur J Nucl Med Mol Imaging. 37(6):1174–1180.PubMedCrossRefGoogle Scholar
  7. Yan R., El-Emir E., Rajkumar V., Robson M., Jathoul A.P., Pedley R.B. and Årstad E. One-pot Formation of a 125I-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. Angewandte Chemie Int Ed., 2011, 50, 6793–679CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • University College NHS Foundation Trust and University College London

There are no affiliations available

Personalised recommendations